indicated that in patients with depression, CHL1 in CD4+ T cells and CD8+ T cells increased and its expression level decreased significantly after treatment, which may prove that CHL1 affects the pathogenesis and treatment of depression through CD4+ T cells and CD8+ T cells (43). Here, CD8A is linked to depressive symptom measurement.